Synthesis of New Thiazole-Privileged Chalcones as Tubulin Polymerization Inhibitors with Potential Anticancer Activities
Authors:
- Hamada HashemHamada Hashem
- Abdelfattah HassanAHAbdelfattah Hassan
- Walid M. AbdelmagidWAWalid M. Abdelmagid
- Ahmed G. K. HabibAHAhmed G. K. Habib
- Mohamed A. A. Abdel-AalMAMohamed A. A. Abdel-Aal
- Ali M. ElshamsyAEAli M. Elshamsy
- Amr El ZawilyAZAmr El Zawily
- Ibrahim Taha RadwanIRIbrahim Taha Radwan
- Stefan BräseSBStefan Bräse
- Ahmed S. Abdel-SameaAAAhmed S. Abdel-Samea
- Safwat M. RabeaSRSafwat M. Rabea
Open Access
- 31 August 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (9) , 1154
Abstract
A series of novel thiazole-based chalcones were evaluated for their anticancer activity as potential tubulin polymerization inhibitors. In vitro anticancer screening for the thiazole derivatives 2a–2p exhibited broad-spectrum antitumor activity against various cancer cell lines particularly Ovar-3 and MDA-MB-468 cells with a GI50 range from 1.55 to 2.95 μΜ, respectively. Compound 2e demonstrated significant inhibition of tubulin polymerization, with an IC50 value of 7.78 μM compared to Combretastatin-A4 (CA-4), with an IC50 value of 4.93 μM. Molecular docking studies of compounds 2e, 2g, and 2h into tubulin further supported these findings, revealing that they bind effectively to the colchicine binding site, mirroring key interactions exhibited by CA-4. Computational predictions suggested favorable oral bioavailability and drug-likeness for these compounds, highlighting their potential for further development as chemotherapeutic agents.Keywords
This publication has 46 references indexed in Scilit:
- Design, synthesis, in vitro antiproliferative evaluation and in silico studies of new VEGFR-2 inhibitors based on 4-piperazinylquinolin-2(1H)-one scaffoldBioorganic Chemistry, 2022
- A new class of cytotoxic agents targets tubulin and disrupts microtubule dynamicsBioorganic Chemistry, 2021
- Novel 4-(piperazin-1-yl)quinolin-2(1H)-one bearing thiazoles with antiproliferative activity through VEGFR-2-TK inhibitionBioorganic & Medicinal Chemistry, 2021
- Tumor angiogenesis: Current challenges and therapeutic opportunitiesCancer Treatment and Research Communications, 2021
- Design, synthesis, and evaluation of new 2-oxoquinoline arylaminothiazole derivatives as potential anticancer agentsBioorganic Chemistry, 2021
- Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosisBioorganic Chemistry, 2021
- Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solutionCancer Letters, 2019
- New antiproliferative 7-(4-(N-substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G2/M phaseBioorganic & Medicinal Chemistry, 2016
- Design and Synthesis of Imidazo[2,1‐b]thiazole–Chalcone Conjugates: Microtubule‐Destabilizing AgentsChemMedChem, 2014
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding SitePharmaceutical Research, 2012